STK39 is a novel kinase contributing to the progression of hepatocellular carcinoma by the PLK1/ERK signaling pathway

Rationale: Protein kinases are critical therapeutic targets for curing hepatocellular carcinoma (HCC). As a serine/threonine kinase, the potential roles of serine/threonine kinase 39 (STK39) in HCC remain to be explored. Methods: The expression of STK39 was examined by RT-qPCR, western blotting and...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Chengfei, Wang, Xiaoming, Fang, Dan, Xu, Ping, Mo, Xiao, Hu, Chao, Abdelatty, Alaa, Wang, Mei, Xu, Haojun, Sun, Qi, Zhou, Guoren, She, Junjun, Xia, Jinglin, Hui, Kam Man, Xia, Hongping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797677/
https://www.ncbi.nlm.nih.gov/pubmed/33500714
http://dx.doi.org/10.7150/thno.48112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797677/
https://www.ncbi.nlm.nih.gov/pubmed/33500714
http://dx.doi.org/10.7150/thno.48112

Ejemplares similares